Skip to main content

Minor Fibrinolytics and Thrombolytics in Clinic

  • Chapter
Advances in Hemostasis and Thrombosis

Part of the book series: Ettore Majorana International Science Series ((LIFESCI,volume 20))

  • 44 Accesses

Abstract

When angiopathic patients arrive in the hospital, they usually present symptomatologies caused by vascular occlusion with stoppage of flow or advanced stenosis with significant reduction of flow. This results in ischemia in the arterial region and stasis in the venous region. Thus total or partial vascular occlusions, almost always thrombotic (sometimes embolic for the arteries), comprise the essence of angiopathies, and represent 90% of the cases that come under our observation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andreotti, L., and Nuzzaci, G., 1961, Modificazioni délia fibrinolisi indotte dalla somministrazione endoarteriosa di acetilcolina, Riv. Crit. Clin. Med., 61: 115.

    Google Scholar 

  • Davidson, J.F., Walker, I.D., and Macallum, H.I., 1975, Study on the mechanism of action of anabolic steroids on fibrinolysis, in: “Progress in Chemical Fibrinolysis and Thrombolysis,” Raven Press, New York.

    Google Scholar 

  • Fischer, A.M., Merton, R.E., Marsch, N.A., Williams, S., Gaffney, P.G., Barrowcliffe, T.W., and Thomas, D.P., 1982, A comparison of penthosane sulphate and heparin. II. Effect of subcutaneous injection, Thromb. Haemost., 47: 109.

    Google Scholar 

  • Gaffney, P.G., Marsch, N.A., and Thomas, D.P., 1982, The influence of heparin and heparin-like substances on the fibrinolytic system in vivo, Seventh International Congress on Thrombosis, Valencia, October 13-16, Abstract, Basel.

    Google Scholar 

  • Pratesi, F., Andreotti, L., Nuzzaci, G., Panerai, A., and Frosecchi, M., 1962, L’acetilcolina a dosi massive nelle arteriopatie obliteranti, Folia Angiologica, 9: 36.

    Google Scholar 

  • Tesi, M., 1975, Aspects of clinical methodology in fibrinolytic therapy, in: “Progress in Chemical Fibrinolysis and Thrombolysis,” Raven Press, New York.

    Google Scholar 

  • Tesi, M., Carini, A., Torrini, F., Trechas, P., and Bronchi, G.F., 1980, Il trattamento col mesoglicano solfato nella terapia dell’arteriopatia aterosclerotica, Riv. Farmacologia e Terapia, XI: 309.

    Google Scholar 

  • Walker, I.D., and Davidson, J.F., 1978, Long-term fibrinolytic enhancement with anabolic steroid therapy, in.: “Progress in Chemical Fibrinolysis and Thrombolysis,” Raven Press, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Tesi, M. (1985). Minor Fibrinolytics and Thrombolytics in Clinic. In: Cajozzo, A., Perricone, R., Di Marco, P., Palazzolo, P. (eds) Advances in Hemostasis and Thrombosis. Ettore Majorana International Science Series, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9424-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9424-6_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9426-0

  • Online ISBN: 978-1-4615-9424-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics